Objective:To explore the protective effect of thioether-cyclized helix B peptide (CHBP)on renal tubular epithelial cells and its mechanism by experiment in vitro.Methods:Human renal proximal tubular epithelial cell line HK-2 cells were cul-tured in vitro and divided into control group,H2 O2 group and CHBP group.Oxidative stress damage models were established by stimulation with 500 μmol/L H2 O2 for 4 h.In CHBP group,20 nmol/L CHBP was added to the culture medium 1 h prior to the establishment of oxidative stress model.After 4 h stimulation with 500 μmol/L H2 O2 ,cell viability,situation of apopto-sis,and severity of oxidative stress damage were measured.The expressions of Binding immunoglobulin protein(BiP),C/EBP homologous protein(CHOP),and the molecular in downstream NF-E2-related factor 2 (Nrf2)signaling pathway were detected by Western blotting and real-time PCR analysis,so as to evaluate the level of endoplasmic reticulum(ER)stress.Results:Oxi-dative stress induced cytotoxic injury could be alleviated by CHBP pretreatment.Kit-8 (CCK-8 )assay and TUNEL showed that,after CHBP pretreatment,cell viability increased,while cell apoptosis,oxidative stress and ER stress decreased.The levels of Nrf2 and heme oxygenase-1(HO-1)were significantly higher in CHBP group than those in H2 O2 group.Conclusions:CHBP pretreatment could alleviate oxidative stress damage of HK-2 cells,and the protective effect may be achieved by inhibi-ting ER stress and activating downstream Nrf2 signaling pathway.

Background: and Purpose The optimal management of patients with acute basilar artery occlusion (BAO) is uncertain. We aimed to evaluate the safety and efficacy of endovascular thrombectomy (EVT) compared to medical management (MM) for acute BAO through a meta-analysis of randomized controlled trials (RCTs). Methods: We performed a systematic review and meta-analysis of RCTs of patients with acute BAO. We analyzed the pooled effect of EVT compared to MM on the primary outcome (modified Rankin Scale [mRS] of 0–3 at 3 months), secondary outcome (mRS 0–2 at 3 months), symptomatic intracranial hemorrhage (sICH), and 3-month mortality rates. For each study, effect sizes were computed as odds ratios (ORs) with random effects and Mantel-Haenszel weighting. Results: Four RCTs met inclusion criteria including 988 patients. There were higher odds of mRS of 0-3 at 90 days in the EVT versus MM group (45.1% vs. 29.1%, OR 1.99, 95% confidence interval [CI] 1.04–3.80; P=0.04). Patients receiving EVT had a higher sICH compared to MM (5.4% vs. 0.8%, OR 7.89, 95% CI 4.10–15.19; P<0.01). Mortality was lower in the EVT group (35.5% vs. 45.1%, OR 0.64, 95% CI 0.42–0.99; P=0.05). In an analysis of two trials with BAO patients and National Institutes of Health Stroke Scale (NIHSS) <10, there was no difference in 90-day outcomes between EVT versus MM. Conclusion In this systematic review and meta-analysis, EVT was associated with favorable outcome and decreased mortality in patients with BAO up to 24 hours from stroke symptoms compared to MM. The treatment effect in BAO patients with NIHSS <10 was less certain. Further studies are of interest to evaluate the efficacy of EVT in basilar occlusion patients with milder symptoms.